At the end of the latest market close, Baudax Bio Inc. (BXRX) was valued at $0.78. In that particular session, Stock kicked-off at the price of $0.79 while reaching the peak value of $0.81 and lowest value recorded on the day was $0.76. The stock current value is $0.77.
Recently in News on June 1, 2021, Baudax Bio Announces $11.9 Million Registered Direct Offering. Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 14,028,520 shares of common stock and warrants to purchase up to an aggregate of 14,028,520 shares of common stock at a purchase price of $0.85 per share and accompanying warrant in a registered direct offering. The warrants have an exercise price of $0.90 per share, will become exercisable upon the later of (i) the six-month anniversary of the closing date of the offering, and (ii) the date of approval by the Baudax Bio shareholders of an increase in the number of Baudax Bio’s authorized shares of common stock, and will expire on December 1, 2026. The closing of the offering is expected to occur on or about June 1, 2021, subject to the satisfaction of customary closing conditions. You can read further details here
Baudax Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1200 on 02/09/21, with the lowest value was $0.7500 for the same time period, recorded on 05/11/21.
Baudax Bio Inc. (BXRX) full year performance was -80.49%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Baudax Bio Inc. shares are logging -83.68% during the 52-week period from high price, and 2.89% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $4.73.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1444247 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Baudax Bio Inc. (BXRX) recorded performance in the market was -22.33%, having the revenues showcasing -34.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 56.04M, as it employees total of 57 workers.
Market experts do have their say about Baudax Bio Inc. (BXRX)
During the last month, 0 analysts gave the Baudax Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2507, with a change in the price was noted -0.5309. In a similar fashion, Baudax Bio Inc. posted a movement of -40.84% for the period of last 100 days, recording 3,953,053 in trading volumes.
Technical breakdown of Baudax Bio Inc. (BXRX)
Raw Stochastic average of Baudax Bio Inc. in the period of last 50 days is set at 2.94%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.10%. In the last 20 days, the company’s Stochastic %K was 21.48% and its Stochastic %D was recorded 28.15%.
Bearing in mind the latest performance of Baudax Bio Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -22.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.37%, alongside a downfall of -80.49% for the period of the last 12 months. The shares increased approximately by -6.72% in the 7-day charts and went up by -25.29% in the period of the last 30 days. Common stock shares were lifted by -34.35% during last recorded quarter.